IDEAS home Printed from https://ideas.repec.org/h/nbr/nberch/10048.html
   My bibliography  Save this book chapter

Long-Run Trends in Patenting

In: R&D, Patents, and Productivity

Author

Listed:
  • John J. Beggs

Abstract

No abstract is available for this item.

Suggested Citation

  • John J. Beggs, 1984. "Long-Run Trends in Patenting," NBER Chapters, in: R&D, Patents, and Productivity, pages 155-174, National Bureau of Economic Research, Inc.
    • Handle: RePEc:nbr:nberch:10048
    as

    Download full text from publisher

    File URL: http://www.nber.org/chapters/c10048.pdf
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Nordhaus, William D, 1969. "An Economic Theory of Technological Change," American Economic Review, American Economic Association, vol. 59(2), pages 18-28, May.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Gregory G. Brunk, 2003. "Swarming of innovations, fractal patterns, and the historical time series of US patents," Scientometrics, Springer;Akadémiai Kiadó, vol. 56(1), pages 61-80, January.
    2. Trajtenberg, Manuel, 1987. "Patents, Citations and Innovations: Tracing the Links," Foerder Institute for Economic Research Working Papers 275436, Tel-Aviv University > Foerder Institute for Economic Research.
    3. Bhattacharjya, Ashoke S., 1996. "Composition of R&D and technological cycles," Journal of Economic Dynamics and Control, Elsevier, vol. 20(1-3), pages 445-470.
    4. Clemente Forero & Andrés Zambrano, 2004. "La dinámica de las publicaciones y las patentes como una aproximación al desarrollo científico y tecnológico de los países," Borradores de Investigación 2977, Universidad del Rosario.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Nejla YACOUB, 2012. "Brevetabilité des médicament, innovation et l’avenir de l’industrie pharmaceutique en Tunisie DRUGS PATENTABILITY INNOVATION AND THE FUTURE OF THE PHARMACEUTICAL INDUSTRY IN TUNISIA THEORETICAL STUDY ," Working Papers 248, Laboratoire de Recherche sur l'Industrie et l'Innovation. ULCO / Research Unit on Industry and Innovation.
    2. Charles I. Jones, 1999. "Growth: With or Without Scale Effects?," American Economic Review, American Economic Association, vol. 89(2), pages 139-144, May.
    3. Uddin, Md Hamid & Mollah, Sabur & Islam, Nazrul & Ali, Md Hakim, 2023. "Does digital transformation matter for operational risk exposure?," Technological Forecasting and Social Change, Elsevier, vol. 197(C).
    4. Taalbi, Josef, 2017. "What drives innovation? Evidence from economic history," Research Policy, Elsevier, vol. 46(8), pages 1437-1453.
    5. Suma Athreye & Lucia Piscitello & Kenneth C. Shadlen, 2020. "Twenty-five years since TRIPS: Patent policy and international business," Journal of International Business Policy, Palgrave Macmillan, vol. 3(4), pages 315-328, December.
    6. Gancia, Gino & Zilibotti, Fabrizio, 2005. "Horizontal Innovation in the Theory of Growth and Development," Handbook of Economic Growth, in: Philippe Aghion & Steven Durlauf (ed.), Handbook of Economic Growth, edition 1, volume 1, chapter 3, pages 111-170, Elsevier.
    7. Chadha, Alka, 2009. "TRIPs and patenting activity: Evidence from the Indian pharmaceutical industry," Economic Modelling, Elsevier, vol. 26(2), pages 499-505, March.
    8. Gustaf Bellstam & Sanjai Bhagat & J. Anthony Cookson, 2021. "A Text-Based Analysis of Corporate Innovation," Management Science, INFORMS, vol. 67(7), pages 4004-4031, July.
    9. Neuhäusler, Peter & Frietsch, Rainer & Rothengatter, Oliver, 2015. "Patentierung computerimplementierter Erfindungen: Aktuelle Rechtslage und ökonomische Implikationen," Discussion Papers "Innovation Systems and Policy Analysis" 46, Fraunhofer Institute for Systems and Innovation Research (ISI).
    10. Beth Woods & James Lomas & Mark Sculpher & Helen Weatherly & Karl Claxton, 2024. "Achieving dynamic efficiency in pharmaceutical innovation: Identifying the optimal share of value and payments required," Health Economics, John Wiley & Sons, Ltd., vol. 33(4), pages 804-819, April.
    11. Paul M. Romer, 1994. "The Origins of Endogenous Growth," Journal of Economic Perspectives, American Economic Association, vol. 8(1), pages 3-22, Winter.
    12. Ben van Hout & Jolian McHardy & Aki Tsuchiya, 2015. "Patent Purchase as a Policy for Pharmaceuticals," Working Papers 2015007, The University of Sheffield, Department of Economics.
    13. Messaoud Zouikri & Mounir Amdaoud, 2018. "Compétences externes et innovation: le cas des firmes de l'industrie manufacturière algérienne," EconomiX Working Papers 2018-37, University of Paris Nanterre, EconomiX.
    14. Bronwyn H. Hall & Vania Sena, 2017. "Appropriability mechanisms, innovation, and productivity: evidence from the UK," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 26(1-2), pages 42-62, February.
    15. Gerlagh , Reyer & Kverndokk , Snorre & Rosendahl , Knut Einar, 2007. "Optimal Timing of Environmental Policy: Interaction Between Environmental Taxes and Innovation Externalities," Memorandum 26/2006, Oslo University, Department of Economics.
    16. Gugler, Klaus & Szücs, Florian & Wiedenhofer, Thomas, 2024. "Environmental Policies and directed technological change," Journal of Environmental Economics and Management, Elsevier, vol. 124(C).
    17. Liu, An-Hsiang & Siebert, Ralph B., 2022. "The competitive effects of declining entry costs over time: Evidence from the static random access memory market," International Journal of Industrial Organization, Elsevier, vol. 80(C).
    18. Kim, Bowon, 1996. "Learning-induced control model to allocate managerial resources for production technology development," International Journal of Production Economics, Elsevier, vol. 43(2-3), pages 267-282, June.
    19. Goetz, Stephan J. & Han, Yicheol, 2020. "Latent innovation in local economies," Research Policy, Elsevier, vol. 49(2).
    20. Nakamura, Hiroshi & Wakutsu, Naohiko, 2020. "Reducing Reimbursement Drug Price Risk to Enhance R&D Incentives without Raising Drug Prices/Expenditures: Implications of Simulations Based on Questionnaire Survey of Pharmaceutical Companies in Japa," Health Policy, Elsevier, vol. 124(7), pages 714-720.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nbr:nberch:10048. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: the person in charge (email available below). General contact details of provider: https://edirc.repec.org/data/nberrus.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.